Report Detail
Purchase Price: $4,750.00
Peripheral Vascular Disease Therapeutic Devices
Peripheral vascular disease (PVD) affects approximately 113 million people worldwide, and there are nearly 11 million new cases each year. As more cases of PVD are diagnosed, minimally invasive interventional procedures will remain an essential therapeutic option for the treatment of severe PVD.
In 2023, global sales of PVD therapeutic devices totaled nearly $6.4bn. Product segments included in this market analysis include vascular stents, atherectomy catheters, thrombectomy catheters, angioplasty catheters, and chronic total occlusion crossing devices. Market drivers include a growing elderly demographic and an associated increase in atherosclerosis and cardiovascular disease. Market limiters include regulatory barriers to market entry, device costs, and a need for greater patient screening.
This new report from Meddevicetracker includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for PVD therapeutic devices. Regions covered by this analysis include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2023–28.
If you are not a subscriber to Meddevicetracker and would like to purchase this report, please send an email to [email protected]. If you would like more information about obtaining a subscription to the Meddevicetracker database and report library, please send an email to [email protected].
Related Medtech Insight articles: